Código QR (código de barras bidimensional)

Enteric Budesonide Treatment in IgA Nephropathy

Introduction: Targeted release formulation (TRF)-budesonide was the first drug approved by regulatory authorities for the management of IgA nephropathy (IgAN) but is not available in many countries. Enteric coated (EC)-budesonide is widely available, but there is a paucity of data in IgAN. Methods:...

Fuld beskrivelse

Na minha lista:
Principais autores: Sanjeev Gulati, Arpita Roy Chaudhary, Sanshriti Chauhan, Karan Saraf, Dinesh Khullar, Sanjiv Jasuja, Vinay Rathore, Hari Shankar Meshram, Brad Rovin
Format: Artigo
Sprog:Inglês
Udgivet: Elsevier 2026-05-01
Serier:Kidney International Reports
Fag:
end- stage kidney disease
IgA nephropathy
infection
oral budesonide
proteinuria
Online adgang:http://www.sciencedirect.com/science/article/pii/S2468024926026434
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker